Search 

Catalyst is a clinical research organisation (CRO)that provides highly customisable solutions to the global biopharmaceutical industry through two established, branded solutions: CatalystOncology and Catalyst Flex. The company provides multi-therapeutic global resourcing and functional services through Catalyst Flex, and full-service oncology CRO offerings through Catalyst Oncology.

With over 800 staff andoffices in the United States and Europe, Catalyst's flexible service model isbuilt from more than a decade of listening to customers, devising customer-centric solutions, and helping customers drive breakthrough clinical studies by leveraging expert teams and innovative technologies.

Clinical Accelerator is an independent European clinical trial management organisation offering a range of clinical research and patient enrolment support services to worldwide clients in the pharmaceutical, biotechnology and medical device industries.

We are specialists in effective and timely patient recruitment, and commit to achieving patient enrolment targets within fixed timelines.

Placing clinical trials in our Eastern European countries of operation allows Clinical Accelerator to achieve significant cost savings for our clients. Fast and large-scale patient recruitment is another important advantage. To ensure excellent quality of our Eastern European trials, we carefully select sites and investigators able to work to the highest quality standards with full ICH GCP compliance.

Clinical Accelerator provides client-tailored services. We are always prepared to adjust our system and procedures to the requirements of virtual, small and medium-sized biotech sponsors or larger pharma companies. We take a proactive role in the management of our projects based on intensive communication with our sponsors and joint commitment to success and always take responsibility for delivering clinical trials to agreed timeframes and within agreed budgets.

We deliver affordable clinical trials solutions with quality and speed!

Erebagen is a synthetic biology company that discovers truly novel bioactive products from microbes by activating previously silent gene clusters 

There is a lot still to be discovered in microbial genomes and Erebagen is using its platform technology to discover new:

• Compounds The structurally diverse bioactive compounds produced by microbes that can act as fantiastic starting points in developing new drugs
• Chemistry How the biocatalysts involved on the production of metabolites work and how they can be used to perform unnatural reactions
• Control How biosynthetic pathways in microbes are controlled by regulators and how we can use these regulators to activate silent parts of the genomes

We are preparing a future round of fund raising and if you would like to hear about our eningeering platform, our buisness plan or how you could work with us please reach out to us

We are hVIVO plc (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials. We provide end-to-end early clinical development services for our broad and long-standing client base of global biopharma companies.

The Group's fast-growing services business includes a unique portfolio of 10+ human challenge models to test a broad range of infectious and respiratory disease products, world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services.

hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capacity via its FluCamp volunteer screening facilities in London and Manchester.

PrecisionLife is built upon a collective ambition to improve our understanding of complex diseases and create better, more personalized therapy options so that we can help patients to live longer, healthier lives.
The PrecisionLife® platform takes a radical new approach to analysis of complex disease biology based on a wide range of patients’ genomic, clinical, and epidemiological data, enabling the discovery of richer and more useful links between patients, disease sub-groups, targets and drugs.
Our powerful patented data analytics and decision support platforms are built on a unique mathematical framework and deep experience in delivering innovative new technologies and products.
Headquartered near Oxford in the UK, we also have offices in the USA, Denmark and Poland.